Review
Modeling the Loading and Unloading of Drugs into Nanotubes
Article first published online: 4 DEC 2008
DOI: 10.1002/smll.200800321
Copyright © 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Additional Information
How to Cite
Hilder, T. A. and Hill, J. M. (2009), Modeling the Loading and Unloading of Drugs into Nanotubes. Small, 5: 300–308. doi: 10.1002/smll.200800321
Publication History
- Issue published online: 29 JAN 2009
- Article first published online: 4 DEC 2008
- Manuscript Revised: 10 JUN 2008
- Manuscript Received: 4 MAR 2008
- Abstract
- Article
- References
- Cited By
Keywords:
- biomaterials;
- drug delivery;
- gene expression;
- modeling;
- nanotubes
Abstract

One of the most promising applications of nanotechnology is that of drug delivery, and in particular the targeted delivery of drugs using nanotubes. Functionalized nanotubes might be able to target specific cells, become ingested, and then release their contents in response to a chemical trigger. This will have significant implications for the future treatment of patients, particularly those suffering from cancer, for whom presently the nonspecific nature of chemotherapy often kills healthy normal cells. Research to date has largely been through experiments investigating toxicity, biocompatibility, solubility, functionalization, and cellular uptake. More recently, the loading and unloading of molecular cargo has gained momentum from both experimental and theoretical investigations. This Review focuses on the loading and unloading of molecular cargo and highlights recent theoretical investigations, which to date have received very little attention in the review literature. The development of nanotube drug-delivery capsules is of vital concern for the improvement of medical treatment, and mathematical modeling tends to facilitate such development and provides a quicker route to applications of the technology. This Review highlights the latest progress in terms of theoretical investigations and provides a focus for the development of the next generation of medical therapeutics.

1613-6829/asset/olbannerleft.gif?v=1&s=abb62bf4c508cccceaedd2e443743ab301acf753)
1613-6829/asset/olbannerright.gif?v=1&s=a0928f6da005e96a3ecfdb9f725fca70c1592474)
